iShares Biotechnology ETF (IBB) — ()
Key Metrics
News
Inside the Recent Strength in Biotech ETFs
Published: by:
Sentiment: Positive ()
Biotech strength is back, with IBB, PBE, FBT, CANC and HELX climbing as cheaper valuations, rate-cut hopes, FDA approvals and strong deal activity fuel biotech gains.
Read More
iShares Biotechnology ETF: The M&A Wave Behind The Suddenly Booming Biotech Sector
Published: by:
Sentiment: Positive ()
The biotech sector, represented by the iShares Biotechnology ETF, has experienced a notable rally in recent months. The key driver of the 40% over the past six months has been …
Read More
Why the Tide in Biotech May Finally Be Turning and What iShares Biotechnology ETF (IBB) Signals
Published: by:
Sentiment: Neutral ()
Acquired 77,000 shares, valued at $11.1 million Transaction represents 8.7% of 13F reportable AUM Post-trade position: 77,000 shares valued at $11.1 million IBB is now the fund's 2nd-largest holding, accounting …
Read More
Biotech ETFs Hovering Around a 52-Week: Here's Why
Published: by:
Sentiment: Positive ()
Biotech-based exchange-traded fund (ETF) iShares Biotechnology ETF IBB has rallied 26.1% over the past six months (as of Oct. 27, 2025), outperforming SPDR S&P 500 ETF Trust SPY (up 24.4%). …
Read More
Trade Tracker: Jason Snipe buys the IBB
Published: by:
Sentiment: Neutral ()
Jason Snipe, Founder and CIO of Odyssey Capital Advisors joins CNBC's “Halftime Report” to detail his latest purchase of the IBB.
Read More
My Top 5 Biotech Stocks Big Pharma Could Buy Next
Published: by:
Sentiment: Positive ()
While AI hype reigns on Wall Street, the healthcare sector is still far from the peaks it reached during the COVID-19 pandemic. And what's more important, many of the biotech …
Read More
Biotech Sector May Flip to Market Leader by Year-End
Published: by:
Sentiment: Neutral ()
The biotech sector has been one of the market's laggards for several years now, and 2025 has been no different, at least on the surface. Year-to-date, the iShares Nasdaq Biotechnology …
Read More
Stock Market ETFs Update: This Week's Trading Ranges
Published: by:
Sentiment: Neutral ()
This is a good time to step back and gain some perspective on the key ETFs I follow as the market anticipates several economic happenings, such as: I start with …
Read More
BBH Vs. IBB: How To Prepare For The Next Biotech Growth Cycle With BBH
Published: by:
Sentiment: Positive ()
Biotech is entering a new growth cycle driven by AI and CRISPR innovation, but current ETF valuations are high and volatility is elevated. BBH offers a concentrated portfolio of leading …
Read More
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
Published: by:
Sentiment: Neutral ()
A smart beta exchange traded fund, the iShares Biotechnology ETF (IBB) debuted on 02/05/2001, and offers broad exposure to the Health Care ETFs category of the market.
Read More
Trump threatens 50% tariffs on copper, 200% on pharmaceuticals
Published: by:
Sentiment: Neutral ()
However, the President did not disclose when the tariffs would take effect.
Read More
IBB: Now Is The Time To Be Contrarian
Published: by:
Sentiment: Positive ()
Biotech stocks have underperformed due to sector rotation, rising rates, and regulatory pressures, but I see a contrarian opportunity emerging. A close look at the recent performance of biotech stocks, …
Read More
Key Stock Market ETFs, Bitcoin Creating A Story
Published: by:
Sentiment: Neutral ()
This past week I wrote a lot about the relationship between silver, gold, bonds, the dollar and S&P 500. I also spoke in the media about those relationships as they …
Read More
Trump Says Pharmaceutical Tariffs Coming in Near Future
Published: by:
Sentiment: Negative ()
President Donald Trump said tariffs on pharmaceuticals will be coming in the “not too distant future” and fit in the category of tariffs imposed on cars, steel, and aluminum. Trump …
Read More
Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages
Published: by:
Sentiment: Negative ()
President Donald Trump's planned tariffs on pharmaceuticals imported into the U.S. could have wide-ranging consequences on the drug supply chain, manufacturers and American patients, some experts told CNBC. The tariffs …
Read More
Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'
Published: by:
Sentiment: Negative ()
Trump doubled down on plans to soon impose "major" pharmaceutical tariffs, while early stage startups dominated digital health funding deals in first quarter.
Read More